<DOC>
	<DOCNO>NCT00560612</DOCNO>
	<brief_summary>The purpose study : 1 ) To document effectiveness tolerability paroxetine treatment subthreshold posttraumatic stress disorder ( PTSD ) veterans early post-deployment period ; 2 ) To determine potential efficacy paroxetine prevent progression anxiety symptom PTSD anxiety disorder , improve overall veteran function .</brief_summary>
	<brief_title>Secondary Prevention With Paroxetine v . Placebo Subthreshold Posttraumatic Stress Disorder ( PTSD )</brief_title>
	<detailed_description>See brief summary</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Stress Disorders , Traumatic</mesh_term>
	<mesh_term>Stress Disorders , Post-Traumatic</mesh_term>
	<mesh_term>Paroxetine</mesh_term>
	<criteria>1 . Veterans 1855 year age 2 . Diagnosis subthreshold PTSD ( least one symptom PTSD symptom cluster B , C , D structure interview ; without functional impairment exposure war zone stressor ) 3 . Written informed consent ; 4 . A negative serum pregnancy test woman childbearing potential . 1 . Lifetime history DSMIV diagnosis bipolar disorder , schizophrenia psychotic disorder , cognitive disorder due general medical condition 2 . History substance dependence within last 3 month 3 . Significant suicide risk serious suicide attempt within last year 4 . Clinically significant medical condition laboratory EKG abnormality 5 . Women childbearing potential unwilling practice acceptable method contraception 6 . Subjects need concurrent use psychiatric medication 7 . History hypersensitivity paroxetine 8 . HADS depression subscale score &gt; 12 9 . Failure respond adequate trial paroxetine ( 20 mg/day x 8 wks ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>March 2011</verification_date>
	<keyword>PTSD</keyword>
	<keyword>Paroxetine</keyword>
	<keyword>Subthreshold</keyword>
</DOC>